Nintedanib in patients with chronic fibrosing Interstitial lung diseases with progressive phenotype: the INBUILD trial

被引:0
作者
Koschel, D. [1 ]
Flaherty, K. R. [2 ]
Wells, A. U. [3 ,4 ]
Cottin, V [5 ]
Devaraj, A. [6 ]
Inoue, Y. [7 ]
Richeldi, L. [8 ]
Walsh, S. [9 ]
Stowasser, S. [10 ]
Coeck, C. [11 ]
Goeldner, R. G. [12 ]
Clerisme-Beaty, E. [10 ]
Schlenker-Herceg, R. [13 ]
Brown, K. K. [14 ]
机构
[1] Fachkrankenhaus Coswig, Dept Resp Med, Coswig, Germany
[2] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
[3] Royal Brompton & Harefield NHS Fdn Trust, Natl Inst Hlth Res Resp Biomed Res Unit, London, England
[4] Imperial Coll, Natl Heart & Lung Inst, London, England
[5] Claude Bernard Lyon 1 Univ, Louis Pradel Hosp, Natl Reference Ctr Rare Pulm Dis, Dept Resp Dis, Lyon, France
[6] Royal Brompton & Harefield NHS Fdn Trust, Dept Radiol, London, England
[7] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Clin Res Ctr, Sakai, Osaka, Japan
[8] Univ Cattolica Sacro Cuore, Fdn Policlin A Gemelli Irccs, Rome, Italy
[9] Imperial Coll, Natl Heart & Lung Inst, London, England
[10] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[11] Scs Boehringer Ingelheim Comm V, Brussels, Belgium
[12] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
[13] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
[14] Natl Jewish Hlth, Dept Med, Denver, CO USA
来源
PNEUMOLOGIE | 2020年 / 74卷
关键词
D O I
10.1055/s-0039-3403297
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
P160
引用
收藏
页码:S106 / S107
页数:2
相关论文
empty
未找到相关数据